Euro-Med Laboratories Phil Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Georgiana Evidente

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	31.8yrs
CEO sahipliği	0.03%
Yönetim ortalama görev süresi	7.7yrs
Yönetim Kurulu ortalama görev süresi	14.5yrs

Son yönetim güncellemeleri

Recent updates

CEO

Georgiana Evidente (63 yo)

31.8yrs

Görev süresi

Mrs. Georgiana S. Evidente serves as the Chief Executive Officer and President of Euro-Med Laboratories Phil., Inc. and is its Director since 1993. Mrs. Evidente joined in 1990 and assisted in the completi...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Georgiana Evidente	CEO, President & Executive Director	no data	Veri yok	0.031% ₱ 1.0m
Johnny Yap	CFO, Executive VP	no data	Veri yok	0.90% ₱ 29.6m
Sandra Pineda	Chief Accountant	no data	Veri yok	Veri yok
Janice Ong	Corporate Secretary & Investment Relation Officer	17.2yrs	Veri yok	0.0013% ₱ 41.1k
Jose Emiterio	Senior VP & Compliance Officer	7.7yrs	Veri yok	0.0050% ₱ 164.5k
David Michael Gabriel	Data Protection Officer & Legal Counsel	no data	Veri yok	Veri yok
Evangeline Baviera	Executive VP & Executive Director	27.8yrs	Veri yok	0.0010% ₱ 33.2k
Enrique Raymond Yap	Senior Vice President of Business Development	4yrs	Veri yok	0.41% ₱ 13.5m
Evelyn Mangguing	Head of Internal Audit	4.8yrs	Veri yok	Veri yok

7.7yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim: EURO 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.7 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Georgiana Evidente	CEO, President & Executive Director	31.8yrs	Veri yok	0.031% ₱ 1.0m
Johnny Yap	CFO, Executive VP	30.8yrs	Veri yok	0.90% ₱ 29.6m
Evangeline Baviera	Executive VP & Executive Director	28.8yrs	Veri yok	0.0010% ₱ 33.2k
William Padolina	Independent Chairman of the Board	25.8yrs	Veri yok	0.00050% ₱ 16.4k
Tomas Maramba	Honorary Chairman Emeritus	14.5yrs	Veri yok	0.031% ₱ 1.0m
Basilio Yap	Vice Chairman of the Board	10.4yrs	Veri yok	0.00050% ₱ 16.4k
Edwin Feist	Independent Vice Chairman of the Board	14.5yrs	Veri yok	0.00028% ₱ 9.2k
Esperanza Cabral	Independent Director	no data	Veri yok	0.000020% ₱ 657.9
Enrique Yap	Director	4.3yrs	Veri yok	0.0010% ₱ 32.9k
Benjamin Yap	Director	8.4yrs	Veri yok	0.000020% ₱ 657.9
Anthony Joseph Gaw	Director	3.4yrs	Veri yok	0.00050% ₱ 16.4k

14.5yrs

Ortalama Görev Süresi

74yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: EURO 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 14.5 yıldır).

Euro-Med Laboratories Phil Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Euro-Med Laboratories Phil., Inc., Annual General Meeting, Jun 19, 2024

Less than half of directors are independent

Less than half of directors are independent

Euro-Med Laboratories Phil., Inc., Annual General Meeting, Jun 15, 2022

Euro-Med Laboratories Phil., Inc., Annual General Meeting, Jun 15, 2022

Recent updates

Dividend of ₱0.06 announced

Euro-Med Laboratories Phil., Inc. Approves Declaration of Cash Dividend, Payable on December 2, 2024

Second quarter 2024 earnings released: EPS: ₱0.02 (vs ₱0.009 in 2Q 2023)

First quarter 2024 earnings released: EPS: ₱0.01 (vs ₱0.009 in 1Q 2023)

Full year 2023 earnings released: EPS: ₱0.07 (vs ₱0.049 in FY 2022)

Euro-Med Laboratories Phil., Inc., Annual General Meeting, Jun 19, 2024

Third quarter 2023 earnings released: EPS: ₱0.02 (vs ₱0.014 in 3Q 2022)

Upcoming dividend of ₱0.035 per share at 4.0% yield

Euro-Med Laboratories Phil., Inc. Declares Cash Dividend, Payable on 27 November 2023

Euro-Med Laboratories Phil., Inc. Declares Cash Dividend, Payable on 27 November 2023

Second quarter 2023 earnings released: EPS: ₱0.009 (vs ₱0.007 in 2Q 2022)

New minor risk - Share price stability

Full year 2022 earnings released: EPS: ₱0.05 (vs ₱0.041 in FY 2021)

Less than half of directors are independent

Euro-Med Laboratories Phil., Inc. Approves Cash Dividend, Payable on 21 November 2022

Second quarter 2022 earnings released: EPS: ₱0.007 (vs ₱0.006 in 2Q 2021)

Full year 2021 earnings released: EPS: ₱0.04 (vs ₱0.051 in FY 2020)

Less than half of directors are independent

Euro-Med Laboratories Phil., Inc., Annual General Meeting, Jun 15, 2022

Euro-Med Laboratories Phil., Inc., Annual General Meeting, Jun 15, 2022

Upcoming dividend of ₱0.015 per share

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS ₱0.01 (vs ₱0.006 in 2Q 2020)

VP, Assistant Secretary & Executive Director has left the company

New 90-day low: ₱2.10

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Market bids up stock over the past week

Market bids up stock over the past week

New 90-day high: ₱2.10

Upcoming Dividend of ₱0.05 Per Share

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş